Bejaoui, Yosra
Humaira Amanullah, Fathima
Saad, Mohamad
Taleb, Sara
Bradic, Martina
Megarbane, Andre
Ait Hssain, Ali
Abi Khalil, Charbel
El Hajj, Nady
Funding for this research was provided by:
Weill Cornell Medicine-Qatar
Qatar Foundation
Article History
Received: 3 August 2023
Accepted: 6 November 2023
First Online: 28 November 2023
Declarations
:
: The study is part of the “Immune Profiling of COVID-19 patients Admitted to ICU study (IMPROVISE) (clinicaltrial.gov identifier NCT0447313). The Institutional Review Board at HMC and Cornell approved the study with record numbers MRC-05–007 and 20–00012, respectively. All research was conducted in accordance with the ethical principles of the Declaration of Helsinki. All participants enrolled in their study or their legal guardians signed a consent form.
: Not applicable.
: The authors declare no competing interests.